Effect of flow configuration and membrane characteristics on membrane fouling in a novel multicoaxial hollow-fiber bioartificial liver
- PMID: 11797682
- DOI: 10.1111/j.1749-6632.2001.tb03845.x
Effect of flow configuration and membrane characteristics on membrane fouling in a novel multicoaxial hollow-fiber bioartificial liver
Abstract
A novel "multicoaxial hollow fiber bioreactor" has been developed consisting of four concentric tubes, the two innermost tubes are called hollow fibers. Bioartificial livers are created by culturing liver progenitors in the space between the two innermost hollow fibers and with culture media contained in the two compartments (intracapillary and extracapillary) sandwiching the cell compartment. The outermost compartment is used for gas exchange. A hydrodynamic model has recently been established to predict the optimum hydraulic permeability and bioreactor operational parameters to create the physicochemical environment found in the liver acinus. However, perfusion with serum-free hormonally-defined media and inoculation of cells introduces membrane fouling into the equation, and this parameter must be incorporated into the model. Using commercially available semipermeable hollow fibers (1 mm [0.65 microm pores] and 3 mm [0.1 microm pores] outer diameters [o.d]), the primary cause of resistance is the middle hollow fiber. Preliminary studies using bioreactors inoculated with isolated rat hepatocytes and perfused with serum-containing culture media demonstrated that the middle hollow fiber is the primary site of fouling, and this fouling ultimately causes cell mortality by blocking the transfer of nutrients. Experiments were performed to determine the best commercially available middle hollow fiber for construction of bioreactors and two 3-mm outer-diameter middle hollow fibers were compared: polypropylene and polysulfone, with 0.2 microm and 0.1 microm pore sizes, respectively. Dead-ended and cross flow configurations were compared for their effectiveness at reducing membrane fouling in the middle hollow fiber by determining the change in resistance with time. The results demonstrate that the 0.2-microm pore size polypropylene hollow fiber is the best choice for construction of the multicoaxial hollow-fiber bioreactor, and that cross flow results in two orders of magnitude lower resistance than dead-ended flow after 36 h.
Similar articles
-
Galactosylated poly(vinylidene difluoride) hollow fiber bioreactor for hepatocyte culture.Tissue Eng. 2005 Nov-Dec;11(11-12):1667-77. doi: 10.1089/ten.2005.11.1667. Tissue Eng. 2005. PMID: 16411812
-
A novel multi-coaxial hollow fiber bioreactor for adherent cell types. Part 1: hydrodynamic studies.Biotechnol Bioeng. 2002 Jan 5;77(1):83-90. doi: 10.1002/bit.10081. Biotechnol Bioeng. 2002. PMID: 11745176
-
Convective flow through a hollow fiber bioartificial liver.Artif Organs. 2003 Nov;27(11):1041-9. doi: 10.1046/j.1525-1594.2003.07074.x. Artif Organs. 2003. PMID: 14616523
-
Progress in bioreactors of bioartificial livers.Hepatobiliary Pancreat Dis Int. 2009 Apr;8(2):134-40. Hepatobiliary Pancreat Dis Int. 2009. PMID: 19357025 Review.
-
Hollow Fiber and Nanofiber Membranes in Bioartificial Liver and Neuronal Tissue Engineering.Cells Tissues Organs. 2022;211(4):447-476. doi: 10.1159/000511680. Epub 2021 Apr 13. Cells Tissues Organs. 2022. PMID: 33849029 Review.
Cited by
-
Liver tissue engineering in the evaluation of drug safety.Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1159-74. doi: 10.1517/17425250903160664. Expert Opin Drug Metab Toxicol. 2009. PMID: 19637986 Free PMC article. Review.
-
A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure.Sci Rep. 2017 Nov 6;7(1):14518. doi: 10.1038/s41598-017-15021-4. Sci Rep. 2017. PMID: 29109530 Free PMC article.
-
Artificial liver support at present and in the future.J Artif Organs. 2006;9(1):17-28. doi: 10.1007/s10047-005-0320-1. J Artif Organs. 2006. PMID: 16614798 Review.
-
Evaluation of a single-use bioartificial liver (BAL) biocartridge consisting of cryopreservable alginate encapsulated liver cell spheroids as a component of HepatiCan™, a novel bioartificial liver device.Front Bioeng Biotechnol. 2025 Aug 1;13:1572254. doi: 10.3389/fbioe.2025.1572254. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40821664 Free PMC article.
-
Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.J Mater Sci Mater Med. 2011 May;22(5):1087-99. doi: 10.1007/s10856-011-4306-7. Epub 2011 Apr 3. J Mater Sci Mater Med. 2011. PMID: 21461918
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous